Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

3 structures for P00861

Entry ID Method Resolution Chain Position Source
1KNW X-ray 210 A A 1-420 PDB
1KO0 X-ray 220 A A 1-420 PDB
AF-P00861-F1 Predicted AlphaFoldDB

No variants for P00861

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for P00861

No associated diseases with P00861

4 regional properties for P00861

Type Name Position InterPro Accession
domain Orn/DAP/Arg decarboxylase 2, C-terminal 32 - 376 IPR022643
domain Orn/DAP/Arg decarboxylase 2, N-terminal 33 - 275 IPR022644
binding_site Orn/DAP/Arg decarboxylase 2, pyridoxal-phosphate binding site 51 - 69 IPR022653
conserved_site Orn/DAP/Arg decarboxylase 2, conserved site 216 - 229 IPR022657

Functions

Description
EC Number 4.1.1.20 Carboxy-lyases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

2 GO annotations of molecular function

Name Definition
diaminopimelate decarboxylase activity Catalysis of the reaction: meso-2,6-diaminopimelate + H(+) = L-lysine + CO(2).
pyridoxal phosphate binding Binding to pyridoxal 5' phosphate, 3-hydroxy-5-(hydroxymethyl)-2-methyl4-pyridine carboxaldehyde 5' phosphate, the biologically active form of vitamin B6.

1 GO annotations of biological process

Name Definition
lysine biosynthetic process via diaminopimelate The chemical reactions and pathways resulting in the formation of lysine, via the intermediate diaminopimelate.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q949X7 LYSA1 Diaminopimelate decarboxylase 1, chloroplastic Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MPHSLFSTDT DLTAENLLRL PAEFGCPVWV YDAQIIRRQI AALKQFDVVR FAQKACSNIH
70 80 90 100 110 120
ILRLMREQGV KVDSVSLGEI ERALAAGYNP QTHPDDIVFT ADVIDQATLE RVSELQIPVN
130 140 150 160 170 180
AGSVDMLDQL GQVSPGHRVW LRVNPGFGHG HSQKTNTGGE NSKHGIWYTD LPAALDVIQR
190 200 210 220 230 240
HHLQLVGIHM HIGSGVDYAH LEQVCGAMVR QVIEFGQDLQ AISAGGGLSV PYQQGEEAVD
250 260 270 280 290 300
TEHYYGLWNA AREQIARHLG HPVKLEIEPG RFLVAQSGVL ITQVRSVKQM GSRHFVLVDA
310 320 330 340 350 360
GFNDLMRPAM YGSYHHISAL AADGRSLEHA PTVETVVAGP LCESGDVFTQ QEGGNVETRA
370 380 390 400 410
LPEVKAGDYL VLHDTGAYGA SMSSNYNSRP LLPEVLFDNG QARLIRRRQT IEELLALELL